Zevotek, Inc

CIK:0001364208|SEC Filings

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	Sep. 30, 2012	Sep. 30, 2011
REVENUES:
Sales	$ 0	$ 374
Cost of sales	0	246
Gross profit	0	128
OPERATING EXPENSES:
Selling	0	14,985
General and administrative	61,486	75,919
Total operating expense	61,486	90,904
Loss from operations	(61,486)	(90,776)
OTHER (EXPENSE):
Interest Expense	(41,222)	(302,346)
Total other expense	(102,708)	(302,346)
Net loss before provision for income taxes	(102,708)	(393,122)
Income taxes	0	0
NET LOSS	$ (102,708)	$ (393,122)
Net loss per common share, basic and fully diluted (in Dollars per share)	$ (0.31)	$ (1.42)
Weighted average number of common shares outstanding, basic and fully diluted (in Shares)	335,527	277,504

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	Sep. 30, 2012	Sep. 30, 2011
Statement of Cash Flows [Abstract]
Net loss	$ (102,708)	$ (393,122)
Common stock issued for services rendered	0	5,000
Common stock issued for interest	0	39
Amortization of beneficial conversion feature	1,534	263,140
Accounts receivable	0	1,907
Inventory	0	246
Prepayments and other current assets	0	(8,200)
Accounts payable and accrued expenses	51,146	49,099
Net cash used in operating activities	(50,028)	(81,891)
CASH FLOWS FROM INVESTING ACTIVITIES:	0	0
Increase in advances payable; net	0	79,100
Proceeds from issuance of convertible notes payable	50,000	0
Net cash provided by financing activities	50,000	79,100
Net decrease in cash and cash equivalents	(28)	(2,791)
Cash and cash equivalents, beginning of period	231	4,737
Cash and cash equivalents, end of period	203	1,946
Interest paid	0	0
Income taxes paid	0	0
Common stock issued for settlement of accrued liabilities	0	6,743
Common Stock issued for purchasing representative agreement	0	5,500
Debt and accrued interest converted for shares of common stock	$ 32,235	$ 30,522

CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2012	Jun. 30, 2012
Cash and cash equivalents	$ 203	$ 231
Total current assets	203	231
Total assets	203	231
Accounts payable and accrued expenses	990,147	939,001
Advances payable	199,183	199,183
Convertible notes payable and demand notes (net of debt discount of -0- and -0- as of September 30, 2012 and June 30, 2012, respectively)	1,285,932	1,285,932
Total current liabilities	2,475,262	2,424,116
Long term portion of convertible notes payable (net of debt discount of $28,446 and -0- as of September 30, 2012 and June 30, 2012, respectively)	71,534	50,000
Total Liabilities	2,546,796	1,214,055
Common stock, $0.00001 par value, 5,000,000,000 shares authorized; 335,527 and 335,527 shares issued and outstanding September 30, 2012 and June 30, 2012, respectively	3	3
Treasury stock, 1 share outstanding September 30, 2012 and June 30, 2012	0	0
Additional paid in capital	5,767,406	5,737,406
Accumulated deficit since re-entering the development stage	(102,708)	0
Accumulated deficit	(8,211,305)	(8,211,305)
Total stockholders' deficit	(2,546,593)	(2,473,885)
Total liabilities and stockholders' deficit	203	231
SeriesAPreferredStockMember
Preferred Stock	1	1
SeriesBPreferredStockMember
Preferred Stock	$ 10	$ 10